Management of non-small cell lung cancer in the era of personalized medicine.

  title={Management of non-small cell lung cancer in the era of personalized medicine.},
  author={Gaetano Rocco and Alessandro Morabito and Alessandra Leone and Paolo Muto and Francesco De Fiore and Alfredo Budillon},
  journal={The international journal of biochemistry & cell biology},
Despite major advances in the molecular definition of the disease, screening and therapy, non-small cell lung cancer (NSCLC) is still characterized by a disappointing overall survival, depending on subtype and tumor stage. To address this challenge, in the last years the therapeutic algorithm of NSCLC has become much more complex and articulated, with different kinds of drugs, including chemotherapy, targeted-based agents, angiogenesis inhibitors and immunotherapy, and multiple lines of… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
5 Extracted Citations
37 Extracted References
Similar Papers

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 37 references

Lung Cancer Genotyping." Chest

  • S. Wang, S. Cang, D. Liu
  • J Hematol Oncol
  • 2016
Highly Influential
5 Excerpts

comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor." Ann Oncol

  • K. Wood, T. Hensing, R. Malik, R. Salgia
  • JAMA Oncol
  • 2016

Similar Papers

Loading similar papers…